Company / Financials
BICYCLE THERAPEUTICS PLC Financials
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$72.6M
FY2025 · +105.8% YoY
Net Income
-$219.0M
FY2025 · -29.5% YoY
Profit Margin
-301.7%
FY2025 · net income / revenue
ROE
-35.9%
FY2025 · return on equity
Total Assets
$717.6M
FY2025
Total Debt
-
FY2025
Equity
$610.0M
FY2025
ROA
-30.5%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.98 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$72.6M+105.8% YoYNet Income HistoryProfit after all expenses and taxes-$219.0M-29.5% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$247.1M-17.7% YoYSG&A Expense HistorySelling, general, and administrative expenses$79.4M+10.0% YoYR&D Expense HistoryResearch and development spending$240.3M+38.9% YoYInterest Expense HistoryCost of borrowing and debt obligations$3.3MIncome Tax HistoryTotal income tax expense$152.0K+103.2% YoYEPS (Basic) HistoryBasic earnings per share-$5.08-33.7% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$5.08-33.7% YoYShares Outstanding HistoryWeighted average diluted shares outstanding69.1M+62.8% YoY